Head to head
Harmony XL Pro vs Lumenis One (2026)
Compare purchase costs, running costs and the evidence behind each device.
Read the comparison overview
- Purchase cost
- The catalog lists $60k–$110k for Harmony XL Pro. No new-price range is on file for Lumenis One. Check the source notes and request current quotes.
- Technology
- Harmony XL Pro: IPL. Lumenis One: Diode laser.
- Practice fit
- Both are listed under multi-app platform. Check each model’s US regulatory status and labeled indications for your intended use.
Multi-app platform
View full device profile →Multi-app platform
View full device profile →Price comparison
New price range
- Alma Harmony XL Pro
- $60k–$110kReported source: Dealer quote · Aug 12, 2026
- Lumenis One
- Not published
Used asking range
- Alma Harmony XL Pro
- $30k–$55kReported source: Used listing · Aug 12, 2026
- Lumenis One
- $8k–$18kSource not documented
Payback calculator
- Alma Harmony XL Pro
- View ROI calculator
- Lumenis One
- View ROI calculator
Next step
Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.
Browse current modelsConsumable economics
Consumable cost / lock-in
- Alma Harmony XL Pro
- Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
- Lumenis One
- —
Service cost
- Alma Harmony XL Pro
- Not published
- Lumenis One
- Not published
FDA clearance
FDA status & indication
- Alma Harmony XL Pro
Read FDA indication wording
“[…] 540-950 nm VL/PL, VP, and SSR Module AFT Handpieces: The Advanced Fluorescence Technology (AFT) 540-950 nm VL/PL, VP, and SSR Module handpieces (with and without contact-cooling) are indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles), lentigines, nevi, melasma, and café-au-lait macules. The treatment of cutaneous lesions including warts, scars and striae. The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI). 570-950 nm SR Module AFT Handpiece: The Advanced Fluorescence Technology (AFT) 570-950 nm SR Module handpiece (with and without contact-cooling) is indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma and ephelides (freckles). The treatment of face and body vascular and pigmented lesions. The treatment of cutaneous lesions, including scars and striae. The treatment of benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI).”
- Lumenis One
- FDA ClearedK030342
Read FDA indication wording
“The Lumenis Family of Intense Pulsed-Light (IPL) and IPL/Nd:YAG laser systems (and the delivery accessories that are used with them to deliver light and/or laser energy) are indicated for use in surgical, aesthetic and cosmetic applications requiring selective photothermolysis (photocoagulation or coagulation) and hemostasis of soft tissue in the medical specialties of general and plastic surgery, and dermatology. Intense Pulsed Light Energy/ Wavelengths (515 - 1200 nm) are indicated for: * The treatment of tattoos and benign pigmented epidermal and cutaneous lesions including warts, scars and striae; LUMENIS, fNC. MODIFICATIONTO IPL AND I P W D : Y A G COMB~NAT~ONPRODUCTFAMIUES CONFlDENTIAL 6 2 V. VI. * The treatment of benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations; The removal of unwanted hair from all skin types, and to effect stable long-term, or permanent2, hair reduction in skin types I-V through selective targeting o f melanin in hair follicles. * Nd:YAG Laser Wavelength (1064 nm) is indicated for the coagulation and hemostasis of vascular lesions and soft tissue, including: * Treatment and clearance of superficial and deep telangectasias (venulectasias)and reticular veins (0.1 - 4.0 mm diameter) of the leg. The removal of unwanted hair from all skin types, and to effect stable long-term, or permanent2, hair reduction in skin types I-V through selective targeting of melanin in hair follicles.”
Which chains run each
Chain adoption
- Alma Harmony XL Pro
- 0 recorded pairings
- Lumenis One
- 0 recorded pairings
Chains using it
- Alma Harmony XL Pro
- —
- Lumenis One
- —
Approved reviews
- Alma Harmony XL Pro
- 0
- Lumenis One
- 0
Specs and platform
Manufacturer
- Alma Harmony XL Pro
- Alma
- Lumenis One
- Lumenis
Built by (OEM)
- Alma Harmony XL Pro
- Alma Lasers Ltd.
- Lumenis One
- Lumenis Be Ltd.
Category
- Alma Harmony XL Pro
- Multi-app platform
- Lumenis One
- Multi-app platform
Technology
- Alma Harmony XL Pro
- AFT IPL + multiple laser modules (IPL)
- Lumenis One
- Universal IPL + 1064 + LightSheer diode (Diode laser)
Launch year
- Alma Harmony XL Pro
- 2015
- Lumenis One
- 2003
Status
- Alma Harmony XL Pro
- Current
- Lumenis One
- Legacy-used-market
Manufacturer source record
- Alma Harmony XL Pro
- No linked source on file.
- Lumenis One
- No linked source on file.
Current alternatives
Current catalog models in related categories. Confirm availability and configuration with the supplier.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.